173 related articles for article (PubMed ID: 35681093)
41. Comparison between the polymerase chain reaction-based screening and the Southern blot methods for identification of fragile X syndrome.
Curtis-Cioffi KM; Rodrigueiro DA; Rodrigues VC; Cicarelli RM; Scarel-Caminaga RM
Genet Test Mol Biomarkers; 2012 Nov; 16(11):1303-8. PubMed ID: 23101592
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory.
Nahhas FA; Monroe TJ; Prior TW; Botma PI; Fang J; Snyder PJ; Talbott SL; Feldman GL
Genet Test Mol Biomarkers; 2012 Mar; 16(3):187-92. PubMed ID: 21992462
[TBL] [Abstract][Full Text] [Related]
43. [Analysis and prenatal diagnosis of FMR1 gene mutations among patients with unexplained mental retardation].
Luo S; He W; Liao Y; Tang W; Li X; Hu L; Du J; Zhang Q; Tan Y; Lin G; Li W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 May; 38(5):439-445. PubMed ID: 33974251
[TBL] [Abstract][Full Text] [Related]
44. Genetic cluster of fragile X syndrome in a Colombian district.
Saldarriaga W; Forero-Forero JV; González-Teshima LY; Fandiño-Losada A; Isaza C; Tovar-Cuevas JR; Silva M; Choudhary NS; Tang HT; Aguilar-Gaxiola S; Hagerman RJ; Tassone F
J Hum Genet; 2018 Apr; 63(4):509-516. PubMed ID: 29379191
[TBL] [Abstract][Full Text] [Related]
45. Detection of Cryptic Fragile X Full Mutation Alleles by Southern Blot in a Female and Her Foetal DNA via Chorionic Villus Sampling, Complicated by Mosaicism for 45,X0/46,XX/47,XXX.
Pandelache A; Francis D; Oertel R; Dickson R; Sachdev R; Ling L; Gamage D; Godler DE
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34073864
[TBL] [Abstract][Full Text] [Related]
46. Fragile X analysis of 1112 prenatal samples from 1991 to 2010.
Nolin SL; Glicksman A; Ding X; Ersalesi N; Brown WT; Sherman SL; Dobkin C
Prenat Diagn; 2011 Oct; 31(10):925-31. PubMed ID: 21717484
[TBL] [Abstract][Full Text] [Related]
47. Fragile X carrier screening and FMR1 allele distribution in the Japanese population.
Otsuka S; Sakamoto Y; Siomi H; Itakura M; Yamamoto K; Matumoto H; Sasaki T; Kato N; Nanba E
Brain Dev; 2010 Feb; 32(2):110-4. PubMed ID: 19211207
[TBL] [Abstract][Full Text] [Related]
48. Fragile X syndrome in a male with methylated premutation alleles and no detectable methylated full mutation alleles.
Hayward B; Loutaev I; Ding X; Nolin SL; Thurm A; Usdin K; Smith CB
Am J Med Genet A; 2019 Oct; 179(10):2132-2137. PubMed ID: 31356000
[TBL] [Abstract][Full Text] [Related]
49. An assessment of screening strategies for fragile X syndrome in the UK.
Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
[TBL] [Abstract][Full Text] [Related]
50. Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles.
Wang JY; Hessl D; Schneider A; Tassone F; Hagerman RJ; Rivera SM
JAMA Neurol; 2013 Aug; 70(8):1022-9. PubMed ID: 23753897
[TBL] [Abstract][Full Text] [Related]
51. Significantly Elevated
Field M; Dudding-Byth T; Arpone M; Baker EK; Aliaga SM; Rogers C; Hickerton C; Francis D; Phelan DG; Palmer EE; Amor DJ; Slater H; Bretherton L; Ling L; Godler DE
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31405222
[TBL] [Abstract][Full Text] [Related]
52. Fragile X full mutation expansions are inhibited by one or more AGG interruptions in premutation carriers.
Nolin SL; Glicksman A; Ersalesi N; Dobkin C; Brown WT; Cao R; Blatt E; Sah S; Latham GJ; Hadd AG
Genet Med; 2015 May; 17(5):358-64. PubMed ID: 25210937
[TBL] [Abstract][Full Text] [Related]
53. High-Throughput Methylation-Specific Triplet-Primed PCR and Melting Curve Analysis for Selective and Reliable Identification of Actionable FMR1 Genotypes.
Rajan-Babu IS; Phang GP; Law HY; Lee CG; Chong SS
J Mol Diagn; 2022 Mar; 24(3):241-252. PubMed ID: 35038595
[TBL] [Abstract][Full Text] [Related]
54. Expanded alleles of the
Wang XH; Song XH; Wang YL; Diao XH; Li T; Li QC; Zhang XH; Deng XH
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054962
[TBL] [Abstract][Full Text] [Related]
55. Altered neural activity in the 'when' pathway during temporal processing in fragile X premutation carriers.
Kim SY; Tassone F; Simon TJ; Rivera SM
Behav Brain Res; 2014 Mar; 261():240-8. PubMed ID: 24398265
[TBL] [Abstract][Full Text] [Related]
56. [Analysis of CGG repeat instability in germline cells from two male fetuses affected with fragile X syndrome].
Duan R; Luo S; Huang W; Li H; Peng Y; Du Q; Wu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):606-9. PubMed ID: 27577204
[TBL] [Abstract][Full Text] [Related]
57. The Fragile X premutation: new insights and clinical consequences.
Van Esch H
Eur J Med Genet; 2006; 49(1):1-8. PubMed ID: 16473304
[TBL] [Abstract][Full Text] [Related]
58. Two novel intragenic variants in the FMR1 gene in patients with suspect clinical diagnosis of Fragile X syndrome and no CGG repeat expansion.
Carroll R; Shaw M; Arvio M; Gardner A; Kumar R; Hodgson B; Heron S; McKenzie F; Järvelä I; Gecz J
Eur J Med Genet; 2020 Oct; 63(10):104010. PubMed ID: 32688058
[TBL] [Abstract][Full Text] [Related]
59. Mechanisms of Genome Instability in the Fragile X-Related Disorders.
Hayward BE; Usdin K
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681027
[TBL] [Abstract][Full Text] [Related]
60. FMR1 allele size distribution in 35,000 males and females: a comparison of developmental delay and general population cohorts.
Kraan CM; Bui QM; Field M; Archibald AD; Metcalfe SA; Christie LM; Bennetts BH; Oertel R; Smith MJ; du Sart D; Bruno D; Wotton TL; Amor DJ; Francis D; Godler DE
Genet Med; 2018 Dec; 20(12):1627-1634. PubMed ID: 29595813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
